✦ LIBER ✦

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

✍ Scribed by Mohamed A Kharfan-Dabaja; Michael Boeckh; Marissa B Wilck; Amelia A Langston; Alice H Chu; Mary K Wloch; Don F Guterwill; Larry R Smith; Alain P Rolland; Richard T Kenney

Book ID: 117792004
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 237 KB
Volume: 12
Category: Article
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(11)70344-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maribavir prophylaxis for prevention of

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

✍ Francisco M Marty; Per Ljungman; Genovefa A Papanicolaou; Drew J Winston; Roy F 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 259 KB

Synthetic Influenza vaccine (FLU-v) stim

Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial

✍ Olga Pleguezuelos; Stuart Robinson; Gregory A. Stoloff; Wilson Caparrós-Wanderle 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Cytomegalovirus glycoprotein-B vaccine w

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

✍ Paul D Griffiths; Anna Stanton; Erin McCarrell; Colette Smith; Mohamed Osman; Ma 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 298 KB

DNA vaccination protects against an infl

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

✍ Suzanne Jones; Kirsten Evans; Hilary McElwaine-Johnn; Michaela Sharpe; John Oxfo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 817 KB

Spray-applied cell therapy with human al

Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial

✍ Robert S Kirsner; William A Marston; Robert J Snyder; Tommy D Lee; D Innes Cargi 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 266 KB

CMX001 for Prevention and Control of CMV

CMX001 for Prevention and Control of CMV Infection in CMV-Seropositive Allogeneic Stem-Cell Transplant Recipients: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial of Safety, Tolerability and Antiviral Activity

✍ F.M. Marty; D. Winston; S.D. Rowley; M. Boeckh; E. Vance; G. Papanicolaou; A. Ro 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 100 KB